Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effectiveness of Corticosteroid Therapy in Patients With Moderate to Severe Coronavirus Disease 2019: A Retrospective Study Publisher



Sadeghi S1 ; Mansourian M2 ; Ebrahimi S3 ; Basiri BK4 ; Nikgoftar N5 ; Jalali S2 ; Sami R6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Medical Student, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Epidemiology and Biostatics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Alzahra Research Institute, Alzahra University Hospital Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. General Practitioner, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. General Physician, Department of Family and Emergency Medicine, Faculty of Medicine, Isfahan University of Medical Science, Isfahan, Iran
  6. 6. Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Nephropharmacology Published:2023


Abstract

Introduction: Ne An acute respiratory infection started in Wuhan city of China in December 2019. The pathogen was discovered as a novel coronavirus from the Coronaviridae family and called the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). According to clinical symptoms and laboratory tests, coronavirus disease 2019 (COVID-19) patients are categorized as asymptomatic, mild, moderate, severe and critical state. Suggested therapies used in moderate to severe COVID-19 disease include corticosteroids, anticoagulation and antiviral drugs (e.g., remdesivir). Objectives: We reviewed the clinical outcomes associated with corticosteroid treatment for COVID-19. Patients and Methods: We planned a retrospective study with 859 patients diagnosed with SARS-CoV-2 infection who were under treatment at Khorshid hospital affiliated with Isfahan University of Medical Sciences, Isfahan, Iran (from February to May 2020). Results: A total of 859 patients were included in this study. The mean age was 63.33±15.45 years of which 43.8% (n = 376) were women. We subcategorized corticosteroids by dose prescribed in smaller groups to show better results. The secondary outcome including the rate of intensive care units (ICUs) admission and death was less with corticosteroid prescription. This study showed, mortality and ICU admission were fewer in patients with ≥51 mg/d and ≥201 mg/d of methylprednisolone therapy, respectively. Conclusion: Based on this study, corticosteroid treatment can reduce both the need for ICU admission and mortality in moderate to severe COVID-19 patients. However, clinical trials are needed to investigate the effect of corticosteroid therapy on the need to mechanically ventilate a patient. © 2023, Society of Diabetic Nephropathy Prevention. All rights reserved.
Related Docs
View other Related Docs
1. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
2. Epidemiological Review of the Coronavirus Disease 2019 (Covid-19) Pandemic up to 15 March 2020, Journal of Isfahan Medical School (2020)
3. Is Non-Invasive Ventilation a Good Choice in All Patients With Severe Covid-19? a Cohort Retrospective Study, Tanaffos (2024)
4. Study of the Possible Origin and Evolution of Coronaviruses, Focusing on Recent 2019 Novel Coronavirus (Covid-19), Journal of Isfahan Medical School (2021)
5. Potential Treatments for Covid-19; a Narrative Literature Review, Archives of Academic Emergency Medicine (2020)
6. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
7. Investigating Methods for Coronavirus Disease 2019 Control: A Systematic Review, Polish Annals of Medicine (2021)
8. Sars-Cov-2, Sars and Mers: Three Formidable Coronaviruses Which Have Originated From Bats; [Sars-Cov-2, Sars-Cov I Mers-Cov: Trzy Grozne Koronawirusy Pochodzace Od Nietoperzy], Postepy Higieny i Medycyny Doswiadczalnej (2021)
Experts (# of related papers)
View all Related Experts
Ramin Sami (25)
Shaghayegh Haghjooy Javanmard (18)
Other Related Docs
9. Comparison of Omicron and Delta Variants of Sars-Cov-2: A Systematic Review of Current Evidence, Infectious Disorders - Drug Targets (2024)
10. Nervous System Involvement in Covid-19: A Review of the Current Knowledge, Molecular Neurobiology (2021)
11. A Review of Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2), Iranian Journal of Medical Microbiology (2020)
12. An Overview on the Genomic Characteristics of the New Coronavirus (2019-Ncov) and the Prospective in Pathogenesis and Treatment of Covid-19 Infection, Journal of Isfahan Medical School (2020)
13. An Updated Review of the Association of Host Genetic Factors With Susceptibility and Resistance to Covid-19, Journal of Cellular Physiology (2021)
14. Intravenous Methylprednisolone Pulse As a Treatment for Hospitalised Severe Covid-19 Patients: Results From a Randomised Controlled Clinical Trial, European Respiratory Journal (2020)
15. A Mini-Review on Cardiovascular and Hematological Complications of Covid-19, Coronaviruses (2021)
16. Covid-19 and Mers: Are Their Chest X-Ray and Computed Tomography Scanning Signs Related?, Journal of Medical Signals and Sensors (2022)
17. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
18. Co-Infection Between the Severe Acute Respiratory Syndrome Coronavirus 2 and the Influenza Type B in Isfahan, Iran, Journal of Research in Medical Sciences (2021)
19. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)
20. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
21. Cardiovascular Complications of Sars-Cov-2 Vaccines: An Overview, Cardiology and Therapy (2022)
22. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
23. Central Nervous System Vasculopathy Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2): A Novel Case Report From Iran, Journal of NeuroVirology (2021)
24. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
25. The Covid-19 Pandemic: A Systematic Review of the Current Evidence; [Пандемия Covid-19: Систематический Обзор Современных Данных], Russian Journal of Infection and Immunity (2020)
26. A Study on the Effect of Aspirin on Clinical Symptoms, Laboratory Indices, and Outcomes in Patients With Covid-19, Journal of Nephropharmacology (2023)
27. A Late Covid-19 Complication: Male Sexual Dysfunction, Prehospital and Disaster Medicine (2020)
28. Differential Diagnostic Utility of Clinical Laboratory Data in Patients With Severe and Non-Severe Covid-19, Shiraz E Medical Journal (2022)
29. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
30. Iranian Pediatric Covid-19 Epidemiology and Clinical Characteristics, Canadian Journal of Infectious Diseases and Medical Microbiology (2021)
31. Controlling and Prevention of Novel Coronavirus Through Health and Safety Protocols in Food: Review Article, Tehran University Medical Journal (2021)
32. Current Status of Covid-19 Pandemic; Characteristics, Diagnosis, Prevention, and Treatment, Journal of Research in Medical Sciences (2020)
33. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
34. Emerging Coronaviruses: First Sars, Second Mers and Third Sars-Cov-2. Epidemiological Updates of Covid-19, Infezioni in Medicina (2020)
35. Convalescent Plasma Therapy for Covid-19: Lessons From Sars-Cov, Mers-Cov, and H1n1 Infection, Acta Medica Indonesiana (2021)
36. Acute Necrotizing Encephalopathy in Adult Patients With Covid-19: A Systematic Review of Case Reports and Case Series, Journal of Clinical Neurology (Korea) (2023)
37. Electrolyte Abnormalities in Hospitalized Covid-19 Patients at Tertiary Referral Centers in Tehran: Hypermagnesemia As a Marker of Fatality: A Retrospective Cross-Sectional Study, Health Science Reports (2023)
38. Sars-Cov-2 and Stroke Characteristics: A Report From the Multinational Covid-19 Stroke Study Group, Stroke (2021)
39. Pi3k/Akt/Mtor Pathway: A Potential Target for Anti-Sars-Cov-2 Therapy, Immunologic Research (2022)
40. A Narrative Literature Review on Traditional Medicine Options for Treatment of Corona Virus Disease 2019 (Covid-19), Complementary Therapies in Clinical Practice (2020)
41. Risk Factors for the Mortality in Hospitalized Patients With Covid-19: A Brief Report, Iranian Journal of Medical Sciences (2021)
42. Infliximab and Intravenous Gammaglobulin in Hospitalized Severe Covid-19 Patients in Intensive Care Unit, Archives of Iranian Medicine (2021)
43. Association of Systemic Complications With Mortality in Coronavirus Disease of 2019: A Cohort Study on Intensive Care Unit Patients, Journal of Research in Medical Sciences (2022)
44. Coenzyme Q10 and Its Therapeutic Potencies Against Covid-19 and Other Similar Infections: A Molecular Review, Advanced Pharmaceutical Bulletin (2023)
45. Fulminant Encephalitis As a Sole Manifestation of Covid-19, Neurological Sciences (2020)
46. Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications, Biomedicine and Pharmacotherapy (2021)
47. Asymptomatic Carriers of Coronavirus Disease 2019 Among Healthcare Workers in Isfahan, Iran, Future Virology (2021)
48. Treatment of Covid-19 With Pentoxifylline: Could It Be a Potential Adjuvant Therapy?, Dermatologic Therapy (2020)
49. Acute Mesenteric Ischemia in a Patient With Covid-19: A Case Report, Archives of Iranian Medicine (2020)
50. Subcutaneous Tocilizumab in Adults With Severe and Critical Covid-19: A Prospective Open-Label Uncontrolled Multicenter Trial, International Immunopharmacology (2020)